Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cistanche Total Glycosides for ALS
NCT00753571Phase 2Unknown
- Sponsor
- Peking University
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cistanche total glycosides in amyotrophic lateral sclerosis (ALS), sponsored by Peking University. Status: unknown.
02
Drugs
cistanche total glycosides
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00753571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753571.